Skip to main content
Erschienen in: Journal of Radiation Oncology 1/2013

01.03.2013 | Original Research

Symptom clusters in patients with brain metastases—a reanalysis comparing different statistical methods

verfasst von: Emily Chen, Luluel Khan, Liying Zhang, Janet Nguyen, Liang Zeng, Gillian Bedard, May Tsao, Cyril Danjoux, Elizabeth Barnes, Arjun Sahgal, Lori Holden, Flo Jon, Kristopher Dennis, Edward Chow

Erschienen in: Journal of Radiation Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to examine whether symptom clusters identified among patients with brain metastases treated with whole brain irradiation were consistent using different statistical methods, and to determine the stability of symptom clusters from baseline to 12 weeks following whole brain radiotherapy.

Methods

Reanalysis of an existing data set compiled from 170 patients with brain metastases was performed using exploratory factor analysis (EFA) and hierarchical cluster analysis (HCA) to extract symptom clusters at baseline, 1, 2, 4, 8, and 12 weeks’ follow-up time points. Symptom clusters identified with these two methods were compared with findings employing principal component analysis (PCA) from our previously published study.

Results

Symptom clusters extracted at baseline and each subsequent follow-up generally varied depending on the analytical method employed. Twelve unique clusters were found at each follow-up with each method, and at only one period in time (8-week follow-up) did all three methods demonstrate the same cluster. Cluster findings using PCA and HCA correlated more strongly with each other than either did with the findings of EFA. Inconsistency in symptom cluster composition was also observed at different time intervals. While constituents of symptom clusters differed over time between the three analytical methods employed, symptoms within determined clusters such as anxiety and depression or fatigue and drowsiness consistently clustered together.

Conclusion

The stability of symptoms pairs observed indicates a robust interrelationship existed between the symptoms involved. Generally, symptom cluster analysis yields different results depending on which statistical method is employed. A key step in achieving consistency in symptom cluster research involves the utilization of a common statistical analysis method. Further research is warranted to determine the best analytical method that should be employed to provide the most clinical relevance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manag 30(1):18–23CrossRef Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manag 30(1):18–23CrossRef
2.
Zurück zum Zitat Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
3.
Zurück zum Zitat Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs quiz 283–4; Jul–Aug;28(4):270–282; quiz 283-4 Kim HJ, McGuire DB, Tulman L, Barsevick AM (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs quiz 283–4; Jul–Aug;28(4):270–282; quiz 283-4
4.
Zurück zum Zitat Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef
5.
Zurück zum Zitat Chow E, Fan G, Hadi S, Wong J, Kirou-Mauro A, Filipczak L (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol (Royal College of Radiologists) 20(1):76–82CrossRef Chow E, Fan G, Hadi S, Wong J, Kirou-Mauro A, Filipczak L (2008) Symptom clusters in cancer patients with brain metastases. Clin Oncol (Royal College of Radiologists) 20(1):76–82CrossRef
6.
Zurück zum Zitat Xiao C (2010) The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 14(5):417–434PubMedCrossRef Xiao C (2010) The state of science in the study of cancer symptom clusters. Eur J Oncol Nurs 14(5):417–434PubMedCrossRef
7.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
8.
Zurück zum Zitat Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171PubMedCrossRef
9.
Zurück zum Zitat Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M et al (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Supportive Care Cancer 14(1):30–37CrossRef Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M et al (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Supportive Care Cancer 14(1):30–37CrossRef
10.
Zurück zum Zitat Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manag 31(1):85–95CrossRef Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manag 31(1):85–95CrossRef
11.
Zurück zum Zitat Kim HJ, Abraham IL (2008) Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nurs 31(5):E1–E10PubMedCrossRef Kim HJ, Abraham IL (2008) Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nurs 31(5):E1–E10PubMedCrossRef
12.
Zurück zum Zitat Skerman HM, Yates PM, Battistutta D (2009) Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 32(3):345–360PubMedCrossRef Skerman HM, Yates PM, Battistutta D (2009) Multivariate methods to identify cancer-related symptom clusters. Res Nurs Health 32(3):345–360PubMedCrossRef
13.
Zurück zum Zitat Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM, Aranda SK (2009) Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust 190(7 Suppl):S99–S104PubMed Breen SJ, Baravelli CM, Schofield PE, Jefford M, Yates PM, Aranda SK (2009) Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust 190(7 Suppl):S99–S104PubMed
14.
Zurück zum Zitat Cheung WY, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Supportive Care Cancer 17(9):1223–1230CrossRef Cheung WY, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Supportive Care Cancer 17(9):1223–1230CrossRef
15.
Zurück zum Zitat Chow E, Fan G, Hadi S, Filipczak L (2007) Symptom clusters in cancer patients with bone metastases. Supportive Care Cancer 15(9):1035–1043CrossRef Chow E, Fan G, Hadi S, Filipczak L (2007) Symptom clusters in cancer patients with bone metastases. Supportive Care Cancer 15(9):1035–1043CrossRef
16.
Zurück zum Zitat Chen ML, Lin CC (2007) Cancer symptom clusters: a validation study. J Pain Symptom Manag 34(6):590–599CrossRef Chen ML, Lin CC (2007) Cancer symptom clusters: a validation study. J Pain Symptom Manag 34(6):590–599CrossRef
17.
Zurück zum Zitat Chen ML, Tseng HC (2006) Symptom clusters in cancer patients. Supportive Care Cancer 14(8):825–830CrossRef Chen ML, Tseng HC (2006) Symptom clusters in cancer patients. Supportive Care Cancer 14(8):825–830CrossRef
18.
Zurück zum Zitat Wang SY, Tsai CM, Chen BC, Lin CH, Lin CC (2008) Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients. J Pain Symptom Manag 35(3):258–266CrossRef Wang SY, Tsai CM, Chen BC, Lin CH, Lin CC (2008) Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients. J Pain Symptom Manag 35(3):258–266CrossRef
19.
Zurück zum Zitat Kirkova J, Walsh D (2007) Cancer symptom clusters—a dynamic construct. Supportive Care Cancer 15(9):1011–1013CrossRef Kirkova J, Walsh D (2007) Cancer symptom clusters—a dynamic construct. Supportive Care Cancer 15(9):1011–1013CrossRef
20.
Metadaten
Titel
Symptom clusters in patients with brain metastases—a reanalysis comparing different statistical methods
verfasst von
Emily Chen
Luluel Khan
Liying Zhang
Janet Nguyen
Liang Zeng
Gillian Bedard
May Tsao
Cyril Danjoux
Elizabeth Barnes
Arjun Sahgal
Lori Holden
Flo Jon
Kristopher Dennis
Edward Chow
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Radiation Oncology / Ausgabe 1/2013
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-012-0024-0

Weitere Artikel der Ausgabe 1/2013

Journal of Radiation Oncology 1/2013 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.